Shionogi Announces U.S. Availability of Mulpleta® (Lusutrombopag) for the Treatment of Thrombocytopenia in Adults with Chronic Liver Disease Scheduled to Undergo a Procedure
This website uses cookies for analytics and functionality purposes. To change your cookie settings or find out more, click here.
If you continue browsing our website, you accept these cookies.
